Nan Cao

Years Active: 2024-2024
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene (2024)
Nan Cao, Fangmei Zhang, Jiang Yin, Jianlei Zhang, Xiqing Bian, Guopei Zheng, Nan Li, Ying Lin, Liyun Luo
LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis. Oncogene 43 (22) (2024)

Nan Cao.css-eqlu8i{font-size:small;padding-left:4px;}